Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1709-1711
doi: 10.1161/ATVBAHA.109.195552
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Koltsova, E.
Right arrow Articles by Ley, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koltsova, E.
Right arrow Articles by Ley, K.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1709.)
© 2009 American Heart Association, Inc.


Editorials

Tyrosine Sulfation of Leukocyte Adhesion Molecules and Chemokine Receptors Promotes Atherosclerosis

Ekaterina Koltsova; Klaus Ley

From the Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, Calif.

Correspondence to Klaus Ley, MD, Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, 9420 Athena Circle Drive, La Jolla, CA 92037. E-mail klaus@liai.org


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

In this issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Westmuckett and Moore describe a prominent role of tyrosine sulfation in hematopoietic cells during atherosclerosis development.1 Atherosclerosis represents a major health problem in developed and developing countries and is the most common underlying process precipitating myocardial infarctions, limb ischemia, and stroke. In the United States alone, more than 60 million people have some form of atherosclerotic vascular disease.2 Atherosclerosis is a complex disease associated with lipid accumulation and formation of atherosclerotic plaque in the major arteries of the body, which can rupture or erode to cause acute thrombosis, arterial occlusion, and necrosis of the dependent tissue.

See accompanying article on page 1730

In a last two decades, it has become clear that immune processes play an important role in atherosclerosis development, plaque formation, and progression of the disease. Although all major types of immune cells are involved in atherosclerosis (reviewed in3), the exact molecular and cellular mechanisms of disease development and progression are not completely understood. Two commonly used mouse models of atherosclerosis are apolipoprotein E-deficient Apoe–/– or low-density lipoprotein (LDL) receptor-deficient Ldlr–/– mice. In both models, LDL cholesterol is elevated, which promotes atherosclerotic lesion formation in locations similar to those in the human disease. Ldlr–/– mice can be reconstituted with bone marrow from donor mice to produce chimeric mice lacking targeted molecules of interest in hematopoietic cells only.

Leukocyte recruitment is critical for chronic inflammation and progression of atherosclerosis. This process is regulated by adhesion molecules and chemoattractants . . . [Full Text of this Article]


Related Article:

Lack of Tyrosylprotein Sulfotransferase Activity in Hematopoietic Cells Drastically Attenuates Atherosclerosis in Ldlr–/– Mice
Andrew D. Westmuckett and Kevin L. Moore
Arterioscler Thromb Vasc Biol 2009 29: 1730-1736. [Abstract] [Full Text] [PDF]